Very early prediction of response to HCV treatment with peg-IFN-alfa-2a and ribavirin in HIV/HCV coinfected patients

The objective of the present study was to find very early viral kinetic markers to predict nonresponse to HCV therapy in a group of HIV/HCV-coinfected patients. Twenty-six patients (15 HCV genotype-1 and 11 genotype-3) were treated with a 48-week regimen of peginterferon-alfa-2a (PEG-IFN) (180 μg/we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Araújo, Evaldo Stanislau A., Dahari, Harel, Neumann, Avidan U, de Paula Cavalheiro, Norma, Melo, Carlos Eduardo, de Melo, Evandro Sobroza, Layden, Thomas J., Cotler, Scott J., Barone, Antônio Alci
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3075977/
https://ncbi.nlm.nih.gov/pubmed/20738775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2893.2010.01358.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares